✨ Free AI Report
FDC Limited: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research FDC Limited
Company Research

FDC Limited: Business Overview, Financials & Competitive Analysis

FDC Limited scores 6/10 on the AskCyborg Cyborg Score (Solid). Established ORS market leader with strong branding and international presence, but facing near-term margin pressures and modest growth rates. In 2024, FDC Limited's revenue was ₹21.08 billion, an increase of 8.50% compared to the previous year's ₹19.43 billion, but net profit of FDC declined 23.60% to Rs 28.30 crore in.

What is FDC Limited's industry? FDC Limited (fdcindia.com) operates in Pharmaceuticals & Drugs - Specialty Formulations and ORS. AskCyborg classifies FDC Limited under Pharmaceuticals & Drugs - Specialty Formulations and ORS in its company registry.

FDC (Fairdeal Corporation) Limited, founded in 1936, is among India's leading fully integrated pharmaceutical companies and a pioneer in manufacturing specialized formulations and oral rehydration salts (ORS). The com...

6/ 10Solid

Cyborg Score thesis

Established ORS market leader with strong branding and international presence, but facing near-term margin pressures and modest...

Read the full analyst-debate transcript →
Industry Pharmaceuticals & Drugs - Specialty Formulations and ORS
3 named competitors
3 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: October 19, 2026
AI-Generated Research
30+ Page Report

Get the Latest FDC Limited Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Analyst-debate audio for FDC Limited

AskCyborg analysts argue the bull and bear cases for FDC Limited across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
FDC Limited OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below

FDC Limited Overview

Pro stress-test →

FDC (Fairdeal Corporation) Limited, founded in 1936, is among India's leading fully integrated pharmaceutical companies and a pioneer in manufacturing specialized formulations and oral rehydration salts (ORS). The company exports its products to approximately 50 countries.

Strategic Profile

Pro stress-test →

Its flagship product Electral commands a 44% market share, dominating the Oral Rehydration Salt market in India. Key brands include Zifi, Electral, Enerzal, Vitcofol, Pyrimon, Zocon, Zoxan, Zathrin, Zipod, Zefu, Cotaryl and Mycoderm. Over the last 5 years, revenue has grown at a yearly rate of 9.25%, slightly below the industry average of 10.04%.

Competitive Landscape

Pro stress-test →

FDC operates in the Health Care sector and Pharmaceuticals sub-sector. Key competitors include Dr. Reddy's Laboratories, Cipla, and J.B. Chemicals & Pharmaceuticals. FDC differentiates through its ORS market dominance and specialized formulations across 14 therapeutic segments.

Industry Context

FDC Limited operates in Pharmaceuticals & Drugs - Specialty Formulations and ORS.

Key facts

Founded: 1936 · Headquarters: Mumbai, India · Employees: 6,970 · Revenue: ₹21.08 billion (FY2024) · Market cap: ₹6,465 crore

What the AI analysts debated

AI-generated and not independently verified: selected findings from the multi-agent debate on FDC Limited.

  • Market-leading Electral brand holds 44% share of India's ORS category with strong consumer loyalty
  • Recent FDA approvals (Cefixime, Fluconazole) expanding US market opportunity and international footprint
+2 more AI-generated counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • February 2026FDC received USFDA approval for Fluconazole tablets in multiple dosages
  • January 2026Dividend declaration of Rs 5 per share announced
  • +1 moreTrack every material event for FDC Limited as it happens. Explore monitoring →
Get alerted when FDC Limited has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

ORS/Electrolyte CategoryCompetes with unbranded ORS players and functional beverage manufacturers→Pharmaceutical FormulationsMajor competitors in anti-infectives, generics, and specialty formulations→NutraceuticalsCompete against energy drink and supplement brands in consumer wellness segment→

Compare FDC Limited with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

FDC Limited operates in Pharmaceuticals & Drugs - Specialty Formulations and ORS. See how the rest of the sector scores on the Cyborg framework.

Browse Pharmaceuticals & Drugs - Specialty Formulations and ORS research →
NEW · MCP server

Ask your AI assistant about FDC Limited

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare FDC Limited and its top competitor on Cyborg Score”
“What did FDC Limited do this quarter?”
“Is FDC Limited a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg research is made

⚔

AI analyst debate, not single-author opinion

Every report is generated by a panel of AI analysts arguing across 11 dimensions, so counter-arguments sit alongside the case. The debate is a reasoning process; it does not independently verify facts.

📊

Dated, not live

The Cyborg Score and recent developments reflect public sources as of the date shown and can miss or lag recent events. Check primary sources before relying on them.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The Cyborg Score is an AI-generated opinion under that framework, not a credit rating or an investment recommendation.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, and news flow, analysed by AI models. Read the methodology →

AI-generated research summary based on public sources; it may contain errors or omissions. Not investment advice. Not reviewed or endorsed by the companies covered. Report an error: legal@askcyborg.com · Terms of Service

Frequently asked questions

What does FDC Limited do?+
FDC (Fairdeal Corporation) Limited, founded in 1936, is among India's leading fully integrated pharmaceutical companies and a pioneer in manufacturing specialized formulations and oral rehydration salts (ORS). The com...
What is FDC Limited's Cyborg Score?+
FDC Limited has a Cyborg Score of 6/10 (Solid). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are FDC Limited's main competitors?+
Named competitors include ORS/Electrolyte Category, Pharmaceutical Formulations, Nutraceuticals. The full competitive landscape is in the AskCyborg report.
How can I get the full FDC Limited research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the FDC Limited research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track FDC Limited over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

Top-scored companies on AskCyborg

The strongest performers across the analyst-debate framework.

9Advantest Corporation9Anthropic9Apple Inc.9Applied Materials, Inc.9Arista Networks9Aritzia Inc.9ASML Holding N.V.9BAE Systems plc9Barrick Mining Corporation9Berkshire Hathaway Inc.